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Abstract
A group of children aged 6–17 years was recruited and followed up for 12 months to study the impact of schistosome
infection on malaria parasite prevalence, density, distribution and anemia. Levels of cytokines, malaria specific antibodies in
plasma and parasite growth inhibition capacities were assessed. Baseline results suggested an increased prevalence of
malaria parasites in children co-infected with schistosomiasis (31%) compared to children infected with malaria only (25%)
(p=0.064). Moreover, children co-infected with schistosomes and malaria had higher sexual stage geometric mean malaria
parasite density (189 gametocytes/ml) than children infected with malaria only (73/ml gametocytes) (p=0.043). In addition, a
larger percentage of co-infected children (57%) had gametocytes as observed by microscopy compared to the malaria only
infected children (36%) (p=0.06). There was no difference between the two groups in terms of the prevalence of anemia,
which was approximately 64% in both groups (p=0.9). Plasma from malaria-infected children exhibited higher malaria
antibody activity compared to the controls (p=0.001) but was not different between malaria and schistosome plus malaria
infected groups (p=0.44) and malaria parasite growth inhibition activity at baseline was higher in the malaria-only infected
group of children than in the co-infected group though not reaching statistical significance (p=0.5). Higher prevalence and
higher mean gametocyte density in the peripheral blood may have implications in malaria transmission dynamics during co-
infection with helminths.
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Introduction
Malaria and schistosomiasis are the most prevalent tropical
diseases in sub-Saharan Africa and together exert a huge burden
of mortality and morbidity as well as contributing to underdevel-
opment of already disadvantaged populations[1]. About 500
million clinical cases of malaria are reported each year whereas at
least 200 million people are infected with schistosomiasis[2]. The
geographical overlap of these diseases commonly occurs resulting
inevitably in frequent co-infections. It is not clear how helminth
infections affect the outcome or the course of malaria caused by P.
falciparum.
Polyparasitism appears to be the rule, rather than the exception,
both at the population level and among individuals residing in
developing countries [3]. Thus, polyparasitism represents co-
endemicity in an epidemiological sense and simultaneous infec-
tions (co-infections) in individual patients in a clinical sense. The
effects of polyparasitism are often clinically inapparent. However,
in some situations, co-infections may exacerbate disease symptoms
due to one of the pathogens. Co-existent infections may also,
under some circumstances, suppress clinical symptoms due to one
or both pathogens. Thus the possibility of synergistic or
antagonistic interactions needs to be taken into account in
planning and implementing interventions, so as to adjust control
priorities and strategies accordingly.
Buck and colleagues reported that helminth infections affect the
clinical manifestations of malaria, specifically that subjects infected
concurrently with S. mansoni and malaria had significantly greater
rates of hepatosplenomegaly compared to those affected by either
disease singly [4]. However, the general conclusion that helminths
exacerbate malaria was challenged by other studies done at the
same time [5,6].
Subsequent investigations revealed a wide range of disparities in
findings, fueling further research in the area. Many studies found
that helminths increased susceptibility to malaria [5,7–11],
whereas others found no such effect [12–14], and still others
reported lower rates of malaria infection during co-infection [15–
18]. However, results on schistosome infections indicate that light
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indicated in one study in which Lyke and colleagues reported that
children aged 4–8 infected with schistosomes showed less malaria,
increased time to first clinical infection and lower parasitemia
compared to non-infected controls, although this did not apply to
older children [15]. In terms of pathological outcomes, increased
hepatosplenomegaly has been reported in intestinal schistosome-
malaria co-infected individuals [10,19,20], while others reported a
protective effect of helminth infection against development of
cerebral malaria [16] and acute renal failure [17]. Due to these
contrary findings, firm conclusions regarding the nature of
helminth-malaria interactions have remained elusive.
There is growing evidence for the protective role of IgG in P.
falciparum infection. Passive transfer of immunoglobulin G (IgG)
has provided protection against P. falciparum blood stage in South
American (Saimiri) monkeys [21,22] and in humans [23,24].
Furthermore, human antibodies efficiently inhibit in vitro P.
falciparum proliferation [23] and mediate opsonization of infected
RBCs [22], a fact exploited in growth inhibition assays. Cytophilic
antibodies (IgG1 and IgG3) are currently thought to be protective
whereas non-cytophilic antibodies (IgG 2 and IgG4) against the
same epitopes are not protective and may instead competitively
block the protective activity of cytophilic ones [21,22,25]. In areas
where malaria is endemic, cytophilic antibodies have been
associated with lower parasitemia [26] or lower risk of malaria
attack [27]. It is of utmost interest to find out how concomitant
schistosome infection affects antibody isotype switching and
balance and ultimately susceptibility or resistance to P. falciparum
malaria.
We have previously described polyparasitism in the study
population comprising children in rural areas of Zimbabwe [28].
During the course of these investigations we found that there is an
extensive overlap of schistosomiasis and malaria in a number of
areas, which include Burma Valley in eastern Zimbabwe as did
others [29], Lake Kariba shores [30] and the Southeastern
Lowveld Estates near Chiredzi [31]. These areas present an
opportunity for the study of the interaction of malaria and
schistosomiasis under field conditions in human subjects. In this
study the aim was to investigate how schistosome infection affects
malaria parasite prevalence, density and distribution in the study
subjects. The impact of co-infection on hemoglobin and malaria
antibody levels and the impact of schistosome treatment with
praziquantel in the children were examined.
Materials and Methods
Study design
The study was a prospective 12-month follow-up of a cohort of
children from the end of one malaria season to the end of the next
malaria season (Figure 1). At each of the two subsequent 6-month
follow up time periods the same parameters were measured and
infected children were given appropriate recommended treatment.
In total, 605 children aged 6–17 years were recruited at baseline
(T0). Each child provided 3 urine samples on 3 consecutive days
for S. haematobium diagnosis and quantitation, a single stool
specimen for S. mansoni and other helminth diagnosis, and a
further two stool specimens for quantitation. Blood was drawn for
malaria and anemia diagnosis. Based on parasitological diagnosis
at recruitment, children were grouped as uninfected (N),
schistosome-only infected (S), malaria-only infected (M) or
schistosome and malaria co-infected (S+M). The same children
were subsequently followed up at two further time points of 6
months (T6) and 12 months (T12), respectively for diagnosis of
malaria and schistosome infections and collection of blood samples
for other study parameters.
Study area and population
The study area is about 40 km east of the city of Mutare and
close to the border with Mozambique. The Burma Valley area is
Author Summary
Malaria and schistosomiasis are the most prevalent tropical
diseases in sub-Saharan Africa and together exert a huge
burden of mortality and morbidity. The geographical
overlap of these diseases among the individuals and at
the population level commonly occurs resulting inevitably
in frequent co-infections. It is not clear how helminth
infections affect the outcome or the course of malaria
caused by P. falciparum. Previous studies have suggested
both exacerbation as well as suppression of symptoms due
to one or both pathogens. Thus the possibility of
synergistic or antagonistic interactions needs to be taken
into account in planning and implementing interventions,
so as to adjust control priorities and strategies accordingly.
The most notable impact of schistosome co-infection
revealed by our studies was at the prevalence of sexual
and asexual stage malaria parasites, which may have
implications on malaria disease severity and transmission
dynamics.
Figure 1. Study Design. The arrows indicate the different times at which urine, blood and stool samples were obtained from study participants for
diagnosis. The malaria seasons at baseline and follow up times are indicated as well as treatment of schistosome infected children with praziquantel
(PZQ).
doi:10.1371/journal.pntd.0000882.g001
Schistosome and Malaria Co-Infection
www.plosntds.org 2 November 2010 | Volume 4 | Issue 11 | e882located in the eastern province of Manicaland with a longitude of
32u 489, latitude of 19u 509 and altitude of 4, 200 m. The area is
mesoendemic for malaria with peak transmission during the rainy
season (November to May) with lower level transmission
throughout the year. Schistosomiasis is also endemic in the area
with transmission mainly in the dry July to October period. This is
a commercial farming area in which irrigation practices aid the
transmission of both malaria and schistosome parasites. The study
participants were drawn from children who attended three
elementary schools (Valhalla, Msapa and Kaswa) within a 10-
mile radius in proximity to Burma Valley Clinic, which provides
health services to the population. These children predominantly
belonged to low-income families who were employed as laborers in
the estates. Only children aged 6–17 years, attending the three
schools and who had been resident in the area for 4 years or more
were included in the study.
Ethical considerations
Samples for this study were obtained from children who agreed
to participate following the granting of written informed consent
by their parents. Samples were collected with ethical clearance
from the Medical Research Council of Zimbabwe and the Johns
Hopkins School of Public Health Institutional Review Board
(USA) (Study number H.26.04.05.20.B2).
Parasitological techniques
Urine samples were collected from each participant between 10
am and 2 pm, on three consecutive days to account for any diurnal
variations in egg shedding by the urine filtration technique [32].
Briefly, 10 ml of urine were forced through a reusable monofil-
ament polyamide (Nytrel) filter (pore size 12–20 mm) using a
syringe. Eggs of S. haematobium (size, 150 by 60 mm), if present, are
unable to pass through the filter. The filter membranes were
stained with Lugol’s iodine to enhance the visibility of eggs under
the microscope. Children were diagnosed as schistosome infected
if S. haematobium eggs were detected in any one or more of their 3
urine samples or schistosome free if none were found.
The formal ether concentration method was used to diagnose S.
mansoni infections and other soil transmitted helminths (STH)
(Necator americanus, Ascaris lumbricoides and Trichuris trichiura)
infections from participants’ samples as described elsewhere [28].
Children were diagnosed as schistosome infected if S. mansoni eggs
were detected in their stool samples or schistosome free if not, and
children who were STH infected were also treated but excluded.
About 5 ml of venous blood was collected from each participant
into two tubes (EDTA coated and plain tubes). Plasma and serum
were stored at 220uC for use in further laboratory tests for
antibody and cytokine levels and their ability to inhibit malaria
parasite growth. Malaria blood smears were prepared from EDTA
blood for diagnosis and determination of P. falciparum burden. P.
falciparum parasitemia was estimated by counting the number of
malaria parasites in random microscope fields containing 200
white blood cells (WBCs) and then multiplying the result by 40
assuming 8000 WBCs/ml [33]. The detection of any P. falciparum
malaria blood stage parasite was conclusive of malaria infection.
Gametocyte counts were also recorded. Hemoglobin levels were
measured for each subject using the Hemocue digital counter (mg/
dl). The children were classified as anemic or non-anemic
according to the WHO age/gender cut-off limits[2].
Treatment of infected children
Children who were infected with schistosomes were treated with
a single dose of praziquantel (40 mg per kilogram of body weight),
whilst those who had STHs received a single 400 mg dose of
albendazole (but excluded from further analyses). Children who
tested positive for malaria were treated at the Burma Valley Clinic
with a combination of chloroquine and sulfadoxine/pyrimeth-
amine in accordance with Ministry of Health and Child Welfare
(Zimbabwe) guidelines (2002).
Total IgG to crude P. falciparum antigen by ELISA
P. falciparum culture (NF54) was grown in vitro and crude antigen
(mixture of all parasite blood stages) harvested for use in ELISA
detection of antibody levels in plasma from the study participants
at the different time points. Cultured parasites were harvested by
centrifugation (800 g, 5 min) and released from RBCs by
treatment with 0.1% saponin (10 min). Parasites were pelleted
(1,800 g, 10 min) and lysed by sonication. The supernatant was
collected after centrifugation at 10, 000 g for 20 min and protein
concentration measured by the bicinchoninic acid assay (BCA). A
100 ml volume per well of 2 mg/ml of P. falciparum crude antigen
was used to coat 96-well plates (Immulon 4 HBX, USA) overnight
at 4uC. Plate was washed 4 times (PBS/0.05%Tween-20) to
remove unbound antigen followed by addition of 200 mlo f5 %
milk/0.1% Tween to block antigen free surfaces of the wells for
1 hr. After washing the plates 4 times, 100-ml plasma samples (at a
dilution of 1:200) were added to each well in duplicate. Plates were
incubated at room temperature for 2 hrs on a rocking platform
followed by 4 washes. Secondary goat anti-human IgG (Kirke-
gaard and Perry Labs, MD, USA) conjugated to horseradish
peroxidase (HRP) at 1:1000 dilution was added (100 ml/well) and
the plates incubated at room temperature for 1 hr. Plates were
washed and color developed by adding 100 ml of substrate 2, 29-
azino-di-(3 ethylbenzthiazoline sulfonic acid (ABTS, Kirkegaard
and Perry Labs, MD, USA) per well and incubated for 30 min in
the dark. Absorbance was read at 405 nm using a multi-scan plate
reader and results expressed as optical density (OD) values and
recorded as ratios compared to a batch of common pooled sera
from malaria exposed adults, which served as the positive control
to allow for comparability of samples run on different days and
different plates. Pooled normal human serum (NHS) obtained
from 12 subjects from the USA with no prior exposure to malaria
served as negative control serum. The results were expressed as
OD ratios by the formula below:
OD ratio for sample~ OD sample{OD negative control ðÞ =
OD positive control{OD negative control ðÞ :
Total IgG, IgG2 and IgG3 to MSP-1 and AMA-1
To quantify IgG isotypes to the merozoite surface protein-1
(MSP-1) and the apical membrane antigen-1 (AMA-1), the same
ELISA protocol as above was used. MSP-142 (FVO) and AMA-1
(FVO) (100 ml per well 1 mg/ml) used to coat plates were provided
by Dr S. Singh of the Malaria Vaccine Development Branch,
National Institutes of Health and Dr D. Lanar of Walter Reed
Army Institute, respectively. For determination of IgG isotypes,
the plates were developed with peroxidase conjugated sheep anti-
human IgG2 or IgG3 (The Binding Site Limited, Birmingham,
UK) at 1 mg/ml.
In vitro growth inhibition assessment by lactate
dehydrogenase (LDH) assay
Antibodies that recognize asexual parasite surface antigens such
as apical membrane antigen-1 (AMA-1) and merozoite surface
Schistosome and Malaria Co-Infection
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vitro [34]. Therefore, the functional activity of antibodies (in
plasma samples), was characterized by in vitro growth inhibition
assays (GIAs). P. falciparum efficiently utilizes acetyl pyridine
adenine dinucleotide (APAD) as a co-factor for the formation of
pyruvate from lactate [35] and hence the LDH assay [36],
validated to match microscopy [37], was used to determine growth
inhibition activity of plasma samples from study subjects. P.
falciparum parasites (W2 strain which is multi-drug resistant [38,39]
at 0.3% parasitemia) were cultured according to Trager and
Jensen’s method [40] in RPMI-1640 (GIBCO, USA) medium
supplemented with 10% inactivated (30 min at 56uC) normal
human serum (NHS), 50 mg/L hypoxanthine (Sigma, USA),
25 mM HEPES (N-2 hydroxyethyl piperazine-N9-2 ethane
sulfonic acid) (Calbiochem, USA) and 2.0 mg/ml sodium
bicarbonate (J.T Baker, NJ, USA) at 2.5% hematocrit. The use
of the drug resistant W2 strain instead of the NF54 strain was to
preclude the need for plasma sample dialysis to ensure that any
residual anti-malarial drugs would not affect GIA [37]. The
parasites were gassed with 5% O2, 5%CO2 and 90% N2 and
incubated at 37uC.
Parasites were synchronized once by 5% D-sorbitol treatment
[41] prior to GIA. Cultures were pelleted by centrifugation at
1,500 rpm for 5 min, supernatant replaced with twice the pellet
volume of 5% sorbitol (w/v in water) and incubated for 10 min at
37uC. The sorbitol was removed by centrifugation and the pellet
washed once with medium and parasites cultured in fresh medium.
After 40 hr of culture, parasitemia was adjusted to 1% (final
concentration) with at least 80% of the parasites at the schizont
stage and plated (200 ml total volume) into 96-well Costar flat-
bottom well plates (Cambridge, USA) in the presence or absence
of test plasma at 1:10 dilution. All plasma samples were tested in
duplicate with positive and negative controls included. The plates
were incubated in 5% CO2,5 %O 2 and 90% N2 using an
incubator at 37uC for 48 hr before the lactate dehydrogenase
assay was carried out.
At the end of the 48 hr growth period, a fixed volume of
parasites (50 ml) was transferred from each well into a micro-
centrifuge tube and spun to pellet the RBCs. The supernatant was
carefully aspirated without disturbing the pellet and 40 ml of cold
PBS was added to each sample and after mixing, the contents
transferred to a microtiter plate. Samples were either processed
immediately or stored at 220uC pending analysis. Immediately
prior to use, LDH buffer (100 mM Tris-HCL, 10 mM sodium
lactate, 0.25% Triton X-100, and pH 7.5) was supplemented with
nitroblue tetrazolium (NBT) 0.5 mg/ml, APAD (0.05 mg/ml) and
phenazine ethosulfate (PES) (0.02 mg/ml). A 100 ml volume of the
complete LDH buffer was added to each well, the plate placed on
a rocking platform and the reaction allowed to proceed for 40 min
in the dark and absorbance read at 650 nm using a multi-scan
plate reader.
Data analysis
Statistical analysis of the data was performed using SPSS 8.0
software (SPSS Inc., Chicago, Illinois). The prevalence of anemia
was compared according to WHO age/gender based classification
and category of infection: not infected (N), schistosome only
infected (S), malaria only infected (M) and schistosome and
malaria co-infected (S+M) using Chi-square tests. The mean
hemoglobin concentration was compared using analysis of
variance (ANOVA) and either a t-test (with Bonferroni correction)
or the Mann-Whitney test. Statistical significance was designated
as P,0.05.
Results
Baseline diagnosis, schistosome burden and criteria for
subject selection
We recruited 605 children (299 girls and 306 boys) at the baseline
survey. However, a total of 120 children of the 605 were excluded
due to presence of other helminth infections or could not be
accurately assigned to any diagnostic group due to missing
diagnostic data. Figure 2 shows the numbers of children that had
adequate blood samples for analyses at T0, T6 and T12. A total of
485 children provided sufficient samples at baseline (T0) for malaria
and schistosomiasis diagnosis and could be classified into 4
categories; not infected (N), schistosome-only infected (S), malaria-
only infected (M), and schistosome and malaria co-infected (S+M)
and constituted the enrolled cohort (Figure 2). At T6 and T12 the
numbers of children examined were 321 and 281, respectively.
However, only about a third of these had complete diagnostic
information and even fewer provided adequate serum samples to
allow antibody and GIA analyses as discussed in this study. The
samples at T0, T6 and T12 that were available for analyses are
shown in parentheses (82 subjects shown at T12 representing the
cohort). The distribution of S. haematobium and S. mansoni infections
among the study subjects at T0 is shown in Table 1. S. haematobium
infectionaccounted for51.3%(249/485/),S.mansoni8.5%(41/485),
whereas, a combination of both infected 13.2% (64/485) of the
children and 27% (131/485) were schistosome free (Table 1). There
was also a significant difference in S. haematobium egg counts per
10 ml of urine between malaria infected (median =109) and
malaria free (median =68) children (p=0.001 Mann-Whitney
Test). On the other hand there was no significant difference in S.
mansoni egg counts between S. mansoni and malaria infected (median
=112) and malaria free (median =106) children (p=0.4).
Wherever possible, all available data on children were utilized
during analysis, however, in some situations subsets of data were used
based on availability of adequate samples. In addition to loss to
follow-up, not all samples had adequate blood samples for all
diagnostic tests for all children at the subsequent follow-up time
points. Baseline diagnostic groups were maintained across follow-up
timepoints for comparison with baseline although the infection status
(malaria and schistosomiasis) may have changed at subsequent
follow-up time points. Figure 2 shows that the final numbers of
children with the complete data at last follow-up time T12 was 82 (45
boys and 37 girls) corresponding to various diagnostic groups, N (11),
S (13), M (24) and S+M (34). The mean age of children in the cohort
was approximately 10 years as was that of the study population.
The effect of schistosome infection on malaria
prevalence at T0, T6 and T12
Schistosome-infected subjects were treated with praziquantel at
each time point, although only a few subjects were re-infected or
newlyinfected. P. falciparum malaria infection prevalence was found to
be higher among S. haematobium infected subjects compared to their
schistosome-free counterparts at T0 (31% versus 25%) (p=0.064)
and T6 (17% versus 7%) (p=0.053) (Figure 3). However, this
difference diminished at T12 as the malaria prevalence levels
observed were 12% for schistosome-infected children and 13.5% for
schistosome-free children.On theotherhand,S. mansoni infection was
not significantly associated with malaria prevalence (p=0.87).
Prevalence and geometric mean parasite densities of
asexual and sexual stages of P. falciparum
A subset of available samples was analyzed for further
estimation of prevalence and density of asexual and sexual forms
Schistosome and Malaria Co-Infection
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infected (M) children had gametocytes by microscopy whereas
57% of the co-infected (S+M) (p=0.06) children had gametocytes
(Figure 4). It thus appears that schistosome and malaria co-
infection may be associated with higher prevalence of gametocytes
in peripheral blood of subjects in this population. Not only did we
observe a tendency for a higher proportion of children with
gametocytes during co-infection (p=0.06, approaching signifi-
cance), but we also noted significantly higher (p=0.05, Mann-
Whitney test) gametocyte geometric mean parasite density during
co-infection (189 gametocytes/ml of blood in S+M group
compared to 73 gametocytes/ml in M group). Conversely, the
mean density of asexual parasites (ring forms) in co-infected
children was lower than that of malaria only infected children
(1764 rings/mli nS +M group (Figure 4) compared to 2509 rings/ml
in the M group. However, this difference was not statistically
significant (p=0.41).
Hemoglobin levels and proportion of children with
anemia at different time points
At recruitment (T0) the baseline mean Hb levels of the four
diagnostic groups showed differences (F=5.048, p,0.0001).
Schistosome infection by itself did not result in a significant drop
in mean Hb levels and malaria infection exerted the greatest
impact on Hb levels (Figures 5a). The differences in Hb levels were
significant between N and M groups (p=0.0001), N and M+S
groups (p=0.0001), but not between N and S (p=0.183). All
infected children at T0 received appropriate treatment and there
was no significant difference detected by ANOVA in mean Hb
levels of the different diagnostic groups at T6 (F=1.520, p=0.189)
nor at T12 (F=0.143, p=0.982).
According to WHO age and gender-based anemia classification,
at T0 38% of the children in group N, 40% in group S, 64% in
Figure 2. Numbers of Recruited Participants and Cohort. Recruitment, loss to follow up and the follow up of cohort after grouping by
diagnosis at baseline survey (T0) and the malaria season status are shown. The numbers of subjects grouped into various diagnostic groups were 485
at T0, 321 at T6 and 281 at T12. At T6 and T12 the numbers of children that tested positive for malaria only were 9 and 14, respectively and those
tested positive for malaria and schistosomes were 33 and 21, respectively. A subset of subjects from each of the 4 categories based on the baseline
diagnosis was maintained at subsequent follow-up time points T6 and T12. These subjects (numbers in parentheses) were chosen based on the
availability of adequate serum volumes for follow-up laboratory studies. Only a representative fraction from the uninfected (N) and schistosome only
(S) infected children were included in analyses due to limited reagent quantities, especially recombinant antigens used in ELISA.
doi:10.1371/journal.pntd.0000882.g002
Table 1. Distribution of S. haematobium and S. mansoni
infection among the study subjects at T0.
S. mansoni infection
status at T0 Total
(2)( +)
S. haematobium
infection
status at T0
(2) 131 41 172
(+) 249 64 313
Total 380 105 485
doi:10.1371/journal.pntd.0000882.t001
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among schistosome positive (SP) and negative (SN) are shown on x-axis. The bars show the percentage values for each survey time point. A higher
proportion of schistosome positive children (black bars) had malaria parasites at T0 (p=0.064) and T6 (p=0.053) compared to the schistosome
negative children (white bars). At T12 the malaria prevalence was not different for the two groups.
doi:10.1371/journal.pntd.0000882.g003
Figure 4. Percentage distributions and geometric mean parasite densities of sexual (gametocyte) and asexual (ring) parasites in
malaria-infected children. Numbers inside bars represent geometric mean parasite density values for sexual (white bars) and asexual (black bars)
in the M (n=14) and S+M (n=28) groups for a subset of subjects for which these data were available. Co-infected children had a higher proportion of
gametocyte infection (p=0.06) and higher mean gametocyte density in blood (p=0.043) compared to malaria only infected children (M).
doi:10.1371/journal.pntd.0000882.g004
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proportion of anemic children at T0 in the groups M and S+Ma s
compared to group N were significantly higher with p=0.0001
and p=0.01, respectively. At T6 and T12 there was no statistically
significant differences in anemia levels across diagnostic groups
(Figure 5b).
Total IgG reactivity to crude P. falciparum antigen at
different time points and to MSP-1 and AMA-1 at T0
We assessed the mean levels of antibody reactivity to crude
malaria antigen extract for all available plasma samples (entire
population) as well as for the cohort (n=82) for each diagnostic
group at the three different time points. Plasma IgG reactivity to
crude P. falciparum antigen extract generally increased with time
over the one-year study period in all groups. The antibody levels
were significantly different among groups at T0 (F=8.169,
p,0.001) andT6 (F=2.633, p=0.05) but subsequently exhibited
no difference in antibody activity to malaria antigens among the
groups at T12 (F=1.162, p=0.280) (Figures 6a and 6b). At T0,
the p values (t-test) for various comparison groups (indicated in
parenthesis) were 0.064 (N and S), 0.001 (N and M), ,0.001 (N
and S+M) and 0.946 (M and S+M). Likewise, p values at T6 were
0.579 (N and S), 0.05 (N and M), 0.018 (N and S+M), and 0.861
(M and S+M). No significant differences were found at T12 among
various comparison groups. In all cases OD ratios were used
Figure 5. Mean hemoglobin levels and prevalence of anemic children for each diagnostic group at different sampling times. At T0,
differences in the hemoglobin levels (Figure 5a) in groups M and S+M were statistically significant (p,0.001 by t-test) as compared to group N. A
comparison between M and S+M and groups N and S revealed non-significant p values, 0.743 and 0.183, respectively. Figure 5b shows results of
proportion of anemic children in various groups, p values at T0 for differences between groups N and M, groups N and S+M and groups N and S were
0.01, 0.001, and 0.273, respectively. The numbers in each bar represent ‘N’ for each group and the error bars represent SEM.
doi:10.1371/journal.pntd.0000882.g005
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plate to plate variation and negative and positive controls were
concurrently run on each plate to ensure plate to plate assay
consistency.
In order to determine whether there were any differences in
plasma levels of antibody reactivity to specific antigens (MSP-1
and AMA-1) at T0, we repeated the ELISA to determine relative
antibody levels in different groups with plates coated with the
purified recombinant MSP-1 and AMA-1 antigens (Figure 6c
entire population and Figure 6d for cohort). These assays did not
reveal any specific patterns among the 4 groups except that anti-
MSP1 antibodies in group M were highest as compared to malaria
uninfected groups and that there were no appreciable differences
between M and S+M groups (Figures 6c and 6d). The same assay
could not be performed for T6 and T12 samples due to limiting
amounts of AMA-1 and MSP-1 antigens available. We also
analyzed serum samples for antigen specific antibody isotypes in
the sera samples from children in the cohort and found that IgG2
antibody reactivity to both specific malaria antigens (MSP-1 and
AMA-1) in the malaria-infected groups (M and S+M) was
markedly increased compared to the reactivity of malaria-free
control groups (N and S) at T0 ( Figures 7a and 7b). Globally there
was a significant difference in antibody activity among the
diagnostic groups p , 0.0001 and individually between either of
the malaria infected groups and the uninfected group, N using the
Kruskal-Wallis test at T0 but not at T6 and T12. At T0, IgG3
isotype antibody reactivity to MSP-1 also differed among
diagnostic groups by ANOVA Subsequent time point reactivity
Figure 6. Comparisons of mean OD ratio of IgG to crude and specific P. falciparum antigens at different time points. The antibody
levels were determined by ELISA from serum samples from children in various diagnostic groups. Generally antibody activity increased with time
from T0 to T12 with higher activity in children who had malaria at baseline. Total number of serum samples for data on entire population in Figure 6a
were T0 (n=446), T6 (n=342), and T12 (n=310). Figure 6b shows data on 82 children in the cohort at all three time points (T0, T6, T12). Figure 6c
shows antibody reactivity results of population sera to MSP-1 (n=193) and AMA-1 (n=198) at T0. Figure 6d shows results for cohort children to MSP-
1 (n=79) and AMA-1 (n=81) at survey T0. Comparison of OD ratios between groups M and S+M or groups N and M for AMA-1 revealed p values of
0.006 and 0.001, respectively by Mann-Whitney test. Error bars represent SEM.
doi:10.1371/journal.pntd.0000882.g006
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We also investigated the levels of cytokines IL-10 and IFN-c in the
serum samples from the various diagnostic groups and did not find
any differences in patterns (data not shown).
In vitro growth inhibition assays
Generally, the total immunoglobulin–specific activity of plasma
from individuals may not be indicative of the level of protection
against malaria, though the level of IgG3 and in some cases IgG1
has been significantly associated with relative protection from
clinical P. falciparum malaria attacks [27]. In order to compare the
functional activity of antibodies from individuals belonging to
different diagnostic groups we carried out GIAs with the individual
plasma samples and calculated the median growth inhibition
potential for each diagnostic group. At baseline (T0) the highest
median percentage inhibition was for the Group M (70%), though
it was not significantly higher than the other groups that were at
50–60% growth inhibition (Figure 8a). At T6, the percentage
growth inhibiting capacity declined precipitously in all groups
especially in Group N which went down to 0% inhibition whereas
all other groups exhibited a 40–50% decline in percent in vitro
growth inhibition (Figure 8b). At T12, 6 months later the percent
in vitro P. falciparum growth inhibiting potential was restored to a
level, a slightly higher than it was at To (Figure 8c), most likely as a
result of re-exposure to malaria during ensuing transmission
season. Figure 8d shows a direct comparison of overall mean
growth inhibition capacity of all subjects’ serum samples at T0, T6
and T12 for the full cohort demonstrating a rapid loss of growth
inhibition capacity of sera at the end of malaria transmission
season. The mean values at T6 were significantly different
(p=0.04) from those at T0 and T12.
Discussion
Our results suggest increased malaria susceptibility during
helminth infection and are in agreement with many studies which
found that helminths increased susceptibility to malaria [5,7–11].
However, other studies found null effect [12–14], and still others
reported lower rates of malaria infection (protection) [15–18]. A
subset of available samples was analyzed to further characterize
differences between asexual and sexual forms in the M and S+M
groups. At T0 only 36% of the malaria-only infected (M) children
had gametocytes whereas 57% of the co-infected (S+M) children
Figure 7. Comparisons of IgG2 and IgG3 isotype-specific antibody activity in serum from subjects in different groups. Cohort sera
samples from three time points (T0, T6 and T12) were analyzed by ELISA to detect IgG2 and IgG3 isotype-specific antibody activity to MSP-1
(Figures 7a and 7c, respectively) and AMA-1 (Figures 7b and 7d, respectively). Error bars represent SEM.
doi:10.1371/journal.pntd.0000882.g007
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infection is associated with a trend towards higher prevalence of
gametocytes in peripheral blood of subjects in this population
(p=0.06). Our results are in agreement with those reported by
Nacher and colleagues who found that helminth infections were
associated with patent gametocyte carriage in Thailand [42] while
Drakeley and colleagues observed a significant positive association
between packed cell volume, reticulocyte count and lymphocyte
count with peripheral blood gametocyte density in malaria
outpatients in The Gambia [43]. Further analysis of the same
subset of samples revealed not only elevated proportion of children
with gametocytes during co-infection, but also significantly higher
gametocyte geometric mean parasite densities (189gametocytes/
ml) compared to 73 gametocytes/ml of the malaria-only infected
group (p=0.05). It is worth noting that the observed differences in
gametocyte prevalence and density were based on microscopic
analysis. The precise reasons for increased gametocyte carriage in
peripheral blood during helminth co-infection remain largely
unknown. The implications of the higher peripheral gametocyte-
mia during co-infection on the potential for malaria transmission
require further study using more sensitive RT-PCR gametocyte
detection methods and mosquito membrane feeding assays which
can establish actual infectivity of gametocytes in the blood and
transmission differences.
A pre-existing helminth infection may predispose children to
development of gametocytemia through events leading to anemia
and tissue hypoxia, which may stimulate P. falciparum gametocy-
togenesis as a survival strategy [42,44]. The physiology of
gametocytogenesis however, is still incompletely understood. In
another study, Nacher and colleagues reported that hemoglobin
levels were lower in gametocyte carriers, peak gametocytemia and
carriage durations were negatively correlated with hemoglobin
Figure 8. Mean growth inhibition activity of different groups at different malaria seasons and survey times. Ability of subjects’ plasma
samples to inhibit P. falciparum growth from each group at T0 (Fig. 8a), T6 (Fig. 8b) and T12 (Fig. 8c) are shown. The box plots display in vitro
percentage growth inhibition activities of P. falciparum by participants’ plasma samples (at 10% concentration) after 48 h growth of synchronized W2
culture. The middle horizontal line in each box indicates the median percentage growth inhibition for each diagnostic group, and the box indicates
the 25
th and 75
th percentiles. The whisker caps extending from each box indicate the minimum and maximum values. Individual marked points
represent a few outlier values. Figure 8d represents mean growth inhibition data for the entire cohort at three transmission seasons (T0, T6, T12).
doi:10.1371/journal.pntd.0000882.g008
Schistosome and Malaria Co-Infection
www.plosntds.org 10 November 2010 | Volume 4 | Issue 11 | e882concentration, median asexual parasitemia and severe malaria
cases were associated with higher gametocytemia compared to
mild malaria following adjustment for confounding variables
[45].Whatever the possible causes, helminth co-infections tend to
be positively correlated with higher gametocytemia and also a
tendency for higher proportion of co-infected children carrying
gametocytes.
At baseline mean Hb levels among the diagnostic groups were
statistically significantly different but were no longer significant at
T6 and T12 following treatment of schistosome infected children
with praziquantel. At T6 the similarly high hemoglobin level may
be attributed to the fact that the children were generally malaria
free in the intervening six months in which helminth infections had
also been cleared from the children by chemotherapy. Malaria
appeared to be the primary cause of anemia and showed no
synergistic or antagonistic interaction with schistosomiasis during
co-infection. Generally the proportion of anemic children was
significantly higher at baseline compared to the proportion anemic
at subsequent follow-up times.
In the present study we also investigated the qualitative and
quantitative differences in various immune parameters in different
groups of children. Generally, the total IgG-specific activity and
levels showed a gradual increase from T0 to T12 reflecting a likely
increase in malaria specific antibody levels expected in an endemic
area. However, at each time point the malaria-infected group
demonstrated significantly higher specific activity compared to the
malaria-free groups. At T0 in the entire study population IgG
levels to MSP-1 were also higher in malaria infected subjects
compared to their malaria free counterparts (p=0.0001).
Recent studies have reported cross-reactivity of IgG3 isotype
antibodies to P. falciparum schizonts and S. mansoni egg antigen(-
SEA) [46]. In this study we also attempted to seek a correlation
between malarial antigen specific IgG3 antibodies and various
infection groups. While our preliminary results revealed a trend for
elevated IgG3 isotype antibodies to MSP-1 and AMA-1 in S+M
group, we do not know if these IgG 3 also cross-react with
schistosome antigens. A systematic analysis involving affinity
purified IgG3 antibodies may further clarify any such possibility.
There was no statistically significant difference among the
diagnostic groups in terms of growth inhibition capacity at T0
(p=0.406), T6 (p=0.602) and T12 (p=0.271) by the Kruskal-
Wallis test. An interesting trend was revealed by the evaluation of
the subjects’ plasma in GIA. At T0 (the end of one malaria season)
the mean growth inhibition activity of plasma samples from all
children included in the analysis was 58% but dropped to 20% at
T6 (at the beginning of the next malaria season) and rose back to
more than 60% at the end of the next malaria season at T12
(Fig. 8d). It is suggested from the box plots that greater growth
inhibition capacity occurred in the malaria-only infected group
and following an intense malaria transmission season, though this
did not reach statistical significance with our current sample size.
This phenomenon deserves to be explored with a larger study
population. The growth inhibition activity of plasma from co-
infected children tended to be lower than that of malaria-only
infected children although antibody levels to malaria antigens were
similar between the two groups at T0. Future investigations are
warranted to determine whether the antimalarial immunoglobu-
lins in the helminth infected malaria subjects are qualitatively
different from those in malaria-only subjects. This fluctuation of
growth inhibition potential seems to suggest that malaria
immunity depends on recent prior exposure to malaria infection.
At T6, at the start of the next malaria season, there was a
dramatically lower level of malaria parasite growth inhibition
capacity as measured by in vitro GIA across all groups. This seems
to suggest that the GIA capacity requires consistent exposure to
malaria parasites in order to remain effective. This drop in growth
inhibition potential occurred despite the rise in IgG specific
activity at T6, suggesting once more that it is not a simple function
of higher antibody activity or levels only. At T12, at the end of
another malaria season, the growth inhibition activity rose across
all the diagnostic groups once again suggesting a temporal
relationship between immunity to malaria and malaria parasite
exposure.
In conclusion, in the present study it was evident that
schistosome co-infection with malaria positively corresponded
with higher incidence and density of gametocytes which likely
leads to more intense malaria transmission. In children with higher
schistosome egg burdens of S. haematobium infection was associated
with higher prevalence of malaria. There was neither a significant
difference in egg burdens nor malaria prevalence in S. mansoni
infected children. Malaria-infected subjects in this population had
lower hemoglobin levels than their malaria-free counterparts and
schistosome infection did not exacerbate anemia. Specific IgG
activity and levels showed a gradual increase over time from T0 to
T12 reflecting increase in malaria specific antibody levels as
expected in an endemic area. Plasma from malaria-infected
subjects showed higher malaria antibody activity in response to
malaria antigens. Growth inhibition activity of plasma was higher
for malaria-only infected children than that from co-infected
children though antibody levels were comparable for the two
groups. Mean GIA of plasma samples from all children included in
the analysis was higher at the end than at the beginning of malaria
seasons. Such fluctuations may need to be taken into account
when evaluating vaccine efficacy in areas of seasonal malaria
transmission. The most notable impact of schistosome co-infection
was revealed by the prevalence of sexual and asexual stage
parasites which may have implications on malaria disease severity
and transmission dynamics.
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